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ABSTRACT 20 
 21 
Bacteriophage-encoded endolysins are highly diverse enzymes that cleave the bacterial 22 
peptidoglycan layer. Current research focuses on their potential applications in medicine, food 23 
conservation and as biotechnological tools. Despite the wealth of applications relying on the 24 
use of endolysin, little is known about the enzymatic properties of these enzymes, especially in 25 
case of endolysins of bacteriophages infecting Gram-negative species. Automated genome 26 
annotations therefore remain to be confirmed. Here, we report the biochemical analysis and 27 
cleavage site determination of a novel Salmonella bacteriophage endolysin, Gp110, which 28 
comprises an uncharacterized Domain of Unknown Function (DUF3380; pfam11860) domain in 29 
its C-terminus and shows the highest specific activity (34,240 U/µM) compared to fourteen 30 
previously characterized endolysins active against peptidoglycan from Gram-negative bacteria 31 
(corresponding to a 1.7- to 364-fold higher activity). Gp110 is a modular endolysin with an 32 
optimal pH of enzymatic activity at pH 8 and an elevated thermal resistance. Reversed phase-33 
HPLC analysis coupled to mass spectrometry showed that DUF3380 has N-acetylmuramidase 34 
(lysozyme) activity cleaving the β-(1,4) glycosidic bond between N-acetylmuramic acid and N-35 
acetylglucosamine residues. Gp110 is active against directly cross-linked peptidoglycan with 36 
various peptide stem compositions, making it an attractive enzyme to develop novel 37 
antimicrobial agents. 38 
  39 
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IMPORTANCE 40 
We report the functional and biochemical characterization of the Salmonella phage endolysin 41 
Gp110. This endolysin has a modular structure with an enzymatically active domain and a cell 42 
wall binding domain. The enzymatic activity of this endolysin outstands all other endolysins 43 
previously characterized using the same methods. A Domain of Unknown Function (DUF3380) is 44 
responsible for this high enzymatic activity. We report that DUF3380 has a N-acetylmuramidase 45 
activity against directly cross-linked peptidoglycan with various peptide stem compositions. This 46 
experimentally verified activity will allow a better classification and understanding of endolysins 47 
enzymatic activities which mostly are inferred by sequence similarities. Three-dimensional 48 
structure predictions for Gp110 suggest a completely different fold compared to previous 49 
enzymes with the same peptidoglycan cleavage specificity, making this endolysins quite unique. 50 
All these features, combined with an increased thermal resistance, make Gp110 an attractive 51 
candidate to engineer novel endolysin-based antibacterials. 52 
  53 
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INTRODUCTION 54 
 55 
Endolysins are bacteriophage (phage)-encoded proteins synthesized at the end of the 56 
lytic infection cycle which degrade the peptidoglycan (PG) of the host bacterium to allow the 57 
viral progeny release (1). The specific activity and structure of these proteins have boosted their 58 
study as new antimicrobials against pathogens including multidrug resistant bacteria (2). 59 
Recently engineered fusions of an endolysin and a selected outer membrane permeabilizing 60 
peptide (Artilysin®s) were shown to display high activity against Gram-negative bacteria (3-5). 61 
In addition, the analysis of endolysins has also led to the development of new biotechnological 62 
tools for bacterial diagnostics and detection, among others (6). 63 
Depending on their origin, the structure of endolysins varies. In general, most of the 64 
endolysins from phages infecting Gram-positive bacteria have a modular structure consisting of 65 
one or two N-terminal enzymatic active domains (EADs) and a C-terminal cell wall binding 66 
domain (CBD) separated by a short linker (7). In contrast, the vast majority of endolysins from 67 
phages infecting Gram-negative bacteria have a globular organization containing only an EAD, 68 
although a number of modular endolysins with different orientations of EADs and CBDs have 69 
been also described (4, 8). The CBDs are responsible for the recognition of the substrate and 70 
the high-affinity binding of these enzymes to the bacterial cell wall (9), whereas the EADs are 71 
responsible for the catalytic activity, i.e., the cleavage of specific bonds within the PG. The PG is 72 
a copolymer of alternating N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc) 73 
residues linked by β-(1,4) glycosidic bonds. Lactyl groups of the MurNAc residues are 74 
substituted by a pentapeptide stem made of L- and D- amino acids which is highly conserved in 75 
 o
n
 June 13, 2016 by KU Leuven University Library
http://aem
.asm
.org/
D
ow
nloaded from
 
 5
Gram-negative species (L-Ala-D-Glu-mDAP-D-Ala-D-Ala) but variable in Gram-positive species 76 
(10). The meso-diaminopimelic acid (mDAP) is substituted by L-lysine in most Gram-positive 77 
species, although it can still be found in Bacillus and Listeria and L-ornithine can be found in the 78 
third position of the stem peptides in the PG of Thermus thermophilus, Spirochetes and 79 
Bifidobacterium globosum (11). 80 
Three groups of enzymatic activities have been associated with endolysins: i) 81 
glycosidases, which include glucosaminidases (EC 3.2.1.52), muramidases or lysozymes (EC 82 
3.2.1.17) and lytic transglycosylases (EC 4.2.2.n1) targeting the β-(1,4) glycosidic bonds of the 83 
sugar backbone;  ii) amidases (EC 3.5.1.28) which target the amide bond between the sugar 84 
backbone and the peptide stems and iii) endopeptidases (EC 3.4.-.-) which hydrolyse the bond 85 
between two amino acids. Only a limited number of studies have analyzed the PG bond cleaved 86 
by endolysins (12-17) and most (automated) annotations of enzymatic specificity only rely on 87 
sequence similarity. As a result, available databases contain inaccurate descriptions of 88 
biochemical specificities. A major problem is associated with the fact that several endolysins 89 
were referred to as lysozymes despite the lack of a biochemical characterization. A typical 90 
example is the endolysin of the T7 bacteriophage originally named as “T7 lysozyme”. This 91 
erroneous designation still persists even though the T7 endolysin was experimentally 92 
demonstrated to be a N-acetylmuramoyl-L-alanine amidase rather than N-acetylmuramidase 93 
(or lysozyme) (18). Another typical example is the bacteriophage lambda lysozyme which has 94 
been shown to display lytic transglycosidase activity (19). Furthermore, sequence similarity 95 
used to assign a putative function to endolysins are sometimes very poor or limited, while Pfam 96 
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designations are often not updated. This can lead to discrepancies between in silico and 97 
experimental results when the cleavage site determination is performed (20). 98 
In this study, we report the functional and biochemical characterization of the modular 99 
Salmonella phage endolysin Gp110. Among the many endolysins we have reported before (21-100 
23) and unpublished endolysins, Gp110 outstands in enzymatic activity (between a 1.7- and 101 
364-fold increase). In addition, the catalytic domain is encoded by an un C-terminal domain of 102 
unknown function (DUF3380; pfam11860). These elements prompted us to characterize Gp110 103 
in more detail, including the determination of its peptidoglycan cleavage specificity.  104 
 105 
MATERIAL AND METHODS 106 
 107 
Bacterial strains and growth conditions 108 
Wild-type Pseudomonas aeruginosa PAO1 strain (ATCC 15692) was kindly provided by 109 
Dr. Pirnay (Lab MCT, Queen Astrid Military Hospital, Neder-Over-Heembeek, Belgium). The food 110 
isolate Salmonella enterica serovar Typhimurium LT2 (ATCC 700720) was provided by the 111 
Centre of Food and Microbial Technology of the KU Leuven (Belgium). Chemically competent 112 
Escherichia coli TOP10 (Thermo Fischer Scientific, Waltham, MA, USA) and E. coli 113 
BL21(DE3)pLysS (Agilent Technologies, Santa Clara, CA, USA) cells were prepared for cloning 114 
and protein recombinant expression, respectively. All these strains were grown at 37°C in 115 
Lysogeny Broth (LB) with shaking. 116 
Cloning, large scale expression and purification  117 
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The sequence for a putative endolysin encoded by the orf110 of the genome of the 118 
uncharacterized Salmonella phage 10 was kindly provided by Dr. K. Makhulatia, (Eliava 119 
Institute, Georgia) and has been deposited to Genbank (Accession N° KU705467). The orf110 120 
was amplified using Phusion High-Fidelity DNA polymerase (Thermo Fischer Scientific, 121 
Waltham, MA, USA) and primers Gp110-F (5’-ATGGCCATTCTAAAACTTGGCAACC-3’) and Gp110-122 
R (5’-GCAGAAACTCTTGTATGCTGCC-3’). The PCR product was cloned into the commercially 123 
available pEXP5-CT/TOPO® expression vector (Thermo Fischer Scientific, Waltham, MA, USA) 124 
according to the manufacturer’s instructions and sequence-verified using the BigDye® 125 
Terminator v1.1 Cycle Sequencing Kit and the ABI3130 Genetic Analyzer (Life Technologies, 126 
Carlsbad, CA, USA). The pEXP5-CT/TOPO® vector provides a C-terminal 6xHis-tag for Ni-NTA 127 
purification. 128 
Recombinant expression of Gp110 was performed in 500 ml LB at 37°C for 4 hours, 129 
using E. coli BL21(DE3)pLysS cells after induction during mid-exponential growth of the culture 130 
(OD600nm = 0.6) with 1 mM of isopropyl-β-D-thiogalactopyranoside (IPTG). After induction, the 131 
pellet was resuspended in lysis buffer (20 mM NaH2PO4-NaOH, 500 mM NaCl, 50 mM imidazole, 132 
pH 7.4) and disrupted with a combination of three freeze-thawing cycles (-80°C/room 133 
temperature) and sonication (10 cycles of 30 s pulse and 30 s rest, Vibra-CellTM Sonics and 134 
Materials, Newtown, CT, USA). Gp110 was purified using the His GraviTrapTM colum kit (GE 135 
Healthcare Life Sciences, Buckinghamshire, UK) following supplier’s recommendations. Wash 136 
buffer and elution buffer were composed of 20 mM NaH2PO4-NaOH, 500 mM NaCl, pH 7.4 with 137 
50 mM or 500 mM imidazole, respectively. Protein purity was estimated by SDS-PAGE. The 138 
Gp110 concentration was determined spectrophotometrically after dialyzing against 139 
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phosphate-buffered saline (PBS) buffer pH 7.4 using Slide-A-Lyzer® MINI dialysis units (Thermo 140 
Fischer Scientific, Waltham, MA, USA). The dialyzed protein was stored at 4°C without observed 141 
loss in activity. 142 
Quantification and characterization of muralytic activity 143 
The hydrolytic activity of Gp110 was quantified on P. aeruginosa PAO1 cells with the 144 
outer membrane (OM) permeabilized by a chloroform/Tris–HCl treatment as described 145 
previously (24). Briefly, mid-exponentially growing (OD600nm = 0.6) P. aeruginosa PAO1 cells 146 
were incubated in a chloroform-saturated 0.05 M Tris/HCl buffer (pH 7.7) for 45 min. 147 
Afterwards, cells were washed in PBS pH 7.4 and concentrated to an OD600nm of 1.5 also in PBS. 148 
To determine the muralytic activity, 30 μl of Gp110 were added to 270 μl of OM permeabilized 149 
P. aeruginosa PAO1 cells (final concentrations between 0.25 and 750 nM Gp110 for the dose-150 
dependence curve) and the resulting decrease in optical density was measured 151 
spectrophotometrically (655 nm) in a Microplate Reader 680 (Bio-Rad, CA, USA). The muralytic 152 
activity of Gp110 was quantified in units/µM according to a standardized method described in 153 
(25).  154 
The effect of pH and temperature on the lytic activity of the endolysin (final 155 
concentration 2 nM) was assessed by the same method with some modifications: for the pH-156 
dependent effect, OM permeabilized P. aeruginosa PAO1 cells were resuspended in universal 157 
pH buffer (150 mM KCl, 10 mM KH2PO4, 10 mM Na-citrate, 10 mM H3BO4) adjusted to pH values 158 
between 3 and 12. To determine the effect of temperature on Gp110 activity, the endolysin 159 
(final concentration 2 nM) was incubated for 10 min at either 30°C, 40°C, 50°C, 60°C, 70°C, 80°C 160 
and 90°C, followed by a cooling step to room temperature. The P. aeruginosa PAO1 substrate 161 
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was resuspended in universal pH buffer adjusted to the optimal pH for the endolysin activity 162 
and the residual activity was tested at room temperature. For both experiments, the relative 163 
muralytic activity was calculated. All assays were performed in triplicate. Statistical analyses 164 
were performed using one-way ANOVA and the Tukey post-hoc test. 165 
In vitro antibacterial activity 166 
The antibacterial assay has been performed similarly as previously described (5). Mid-167 
exponentially growing P. aeruginosa PAO1 and S. Typhimurium LT2 cells (OD600 nm = 0.6) were 168 
diluted in 5 mM HEPES-NaOH (pH 7.4) to a final density of 106 CFU/ml. Next, 100 µl of these 169 
cultures were mixed with 50 µl of Gp110 (2.5 µM final concentration, dialyzed against 170 
phosphate-buffered saline pH 7.4) and 50 µl of 5 mM HEPES-NaOH (pH 7.4) or EDTA (0.5 mM 171 
final concentration)/malate/lactate (both with a final concentration of 10 mM) dissolved in the 172 
same buffer. As a control 100 µl of cells, 50 µl of 5 mM HEPES-NaOH (pH 7.4) and 50 µl PBS pH 173 
7.4 were used. After incubation for 30 min at room temperature, mixtures were diluted in PBS 174 
pH 7.4 and plated on LB agar plates. The antibacterial activity is quantified after 18h incubation 175 
at 37°C as the relative inactivation in logarithmic units (= log10(N0/Ni) with N0= number of 176 
untreated cells and Ni= number of treated cells counted after incubation). 177 
Analysis of PG fragments solubilized by Gp110 178 
 The PG bond cleaved by Gp110 was determined using E. coli BW25113 Δlpp PG as a 179 
substrate. PG was extracted as previously described using boiling SDS (26). A total of 500 µg of 180 
pure PG was digested overnight at 37°C with 0.5 mg/ml of Gp110 in a final volume of 200 µl. As 181 
a control, the same amount of PG was digested with 0.25 mg/ml of Streptomyces globisporus 182 
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mutanolysin (Sigma-Aldrich, Missouri, USA) in 25 mM phosphate buffer pH 6. After 183 
centrifugation at 20,000 × g for 15 min, soluble muropeptides were reduced with sodium 184 
borohydride and separated by reverse-phase HPLC (RP-HPLC) on a Hypersil aQ C18 column (3 185 
µm; 2.1 by 200 mm; ThermoFisher Scientific, Waltham, MA, USA) coupled to an Agilent 6500 186 
Series Q-TOF LC/MS System. Muropeptides were eluted at a flow rate of 0.25 ml/min with a 0 187 
to 15% gradient (buffer A: 0.1% (v/v) formic acid in water; buffer B: 0.1% (v/v) formic acid in 188 
acetonitrile) applied between 6 and 40 min. Bacillus subtilis 168 and Aerococcus viridans ATCC 189 
10400 PG were also used as substrates. Hydrolysis conditions used for B. subtilis and A. viridans 190 
PG were similar as the ones described for E. coli PG. 191 
Nucleotide sequence accession number 192 
 The DNA sequence of orf110 was deposited in GenBank under the accession number 193 
KU705467. 194 
 195 
RESULTS 196 
 197 
In silico analysis of Gp110 198 
Bioinformatic analysis of the Salmonella phage 10 genome revealed that orf110 encodes 199 
a 264-amino acid protein (deduced molecular mass 28.9 kDa) predicted to be a putative 200 
endolysin by HHpred (27), with some similarities (21%) with Pseudomonas phiKZ phage 201 
endolysin (E-value 3x10-20). Sequence similarity searches by Blastp (28) indicate that Gp110 has 202 
a 100% identity with predicted peptidoglycan binding proteins from three other Salmonella 203 
phages (PhiSH19, vB_SalM_SJ3 and Det7). Conserved domains analysis by Pfam (29) showed 204 
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that Gp110 has a modular structure, with an N-terminal PG_binding_1 domain (pfam01471) 205 
and a C-terminal DUF3380 domain (pfam11860). PG_binding_1 from Gp110 has specific 206 
repeated motifs (DGIFGKAT and DGIAGPKT), a feature that seems to be common in proteins 207 
interacting with repetitive structures like peptidoglycan (30). These motifs match the consensus 208 
sequence (D-G-(Pho)2-G-K/N-G/N-T; Pho = hydrophobic amino acid) previously found in other 209 
endolysins with a Gram-negative background (21, 23). The DUF3380 domain is found in viruses 210 
and bacteria, normally associated to PG_binding_1, and belongs to a family of functionally 211 
uncharacterized proteins. 212 
Biochemical characterization of Gp110 peptidoglycan-degrading activity 213 
The predicted PG hydrolytic activity of Gp110 was confirmed and characterized using 214 
OM-permeabilized P. aeruginosa cells as a substrate (24) to allow the endolysin to reach the PG 215 
layer and exert its enzymatic activity, which is measured by a turbidity assay (25).  216 
Incubation of Gp110 with the substrate in universal buffer adjusted to different pHs showed 217 
that this enzyme is active at pH values ranging from 4 to 11, maintaining between 16.0 ± 2.67% 218 
and 47.0 ± 6.9% of its maximal activity at pH 4 and 11, respectively. The highest activity is 219 
achieved in the pH range of 6-9 (between 83.6 ± 13.0% and 93.6 ± 1.4%, respectively), (Figure 220 
1.). Of note is the significant decrease in activity below pH 6 and above pH 9, losing >50% of the 221 
activity (p < 0.05). Gp110 activity shows no significant loss in activity upon a 10 min heat 222 
exposure to temperatures between 20 and 60°C. Above 60°C the activity gradually decreases 223 
with a remaining activity of 26.7 ± 7.0% after 10 min at 90°C (Figure 2.). 224 
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The specific activity of Gp110 was calculated at optimal pH under substrate-saturating 225 
conditions from the slope of the linear regression of the corresponding dose-dependent 226 
saturation curve as previously described (25) (Figure 3.). A linear dose-response was observed 227 
between 0.25 and 1.25 nM Gp110. According to this method the specific activity of Gp110 was 228 
calculated to be 34,240 units/µM, corresponding to a complete clarification of a turbid cell 229 
culture in approximately 10 and 20 minutes with 10 and 1 nM Gp110, respectively. 230 
Gp110 antibacterial activity 231 
The in vitro antibacterial activity of the endolysin was tested against P. aeruginosa PAO1 and S. 232 
Typhimurium LT2 in the presence or absence of EDTA, malate and lactate as OM permeabilizers 233 
(31). As expected, the activity of 2.5 µM Gp110 alone was insignificant against both strains. 234 
However, addition of 0.5 mM EDTA, together with the 2.5 µM Gp110, resulted in a reduction of 235 
2.74 ± 0.11 log-units in case of P. aeruginosa PAO1, corresponding to nearly a 99.9% reduction 236 
in the number of viable cells, and 0.38 ± 0.18 log units in case of S. Typhimurium LT2 cells. The 237 
addition of EDTA alone reduced the cell number with 0.62 ± 0.06 and 0.28 ± 0.29 log units for P. 238 
aeruginosa and S. Typhimurium, respectively. Other OM permeabilizers such us malate and 239 
lactate, did not improve significantly the antibacterial activity of the endolysin against S. 240 
Typhimurium LT2 (data not shown). 241 
Determination of Gp110 PG cleavage specificity by LC-MS 242 
 To determine the PG bond cleaved by the DUF3380 domain in Gp110, purified E. coli PG 243 
was incubated in the presence of recombinant Gp110 and soluble fragments were analyzed by 244 
rp-HPLC coupled to MS (Figure 4.). The muropeptide profile obtained for Gp110 is very similar 245 
 o
n
 June 13, 2016 by KU Leuven University Library
http://aem
.asm
.org/
D
ow
nloaded from
 
 13
to the one obtained for the N-acetylmuramidase mutanolysin (Figure 4A.), suggesting that 246 
Gp110 cleaves the β-1,4 glycosidic bonds of the PG sugar backbone. The major monomer (peak 247 
4, Figure 4A.) generated after the digestion of the PG with Gp110 yielded a peak with an m/z at 248 
942.415 matching the theoretical value expected for a disaccharide-tetrapeptide (Figure 4B.) 249 
thus confirming the glycosidase activity. To determine whether DUF3380 possesses N-250 
acetylmuramidase or N-acetylglucosaminidase activity, tandem mass spectrometry was further 251 
performed on the major monomer (peak 4). The fragmentation event leading to the loss of a 252 
non-reduced GlcNAc residue (203.078 atomic mass units) indicated that Gp110 displays N-253 
acetylmuramidase activity (Figure 4C.) instead of an N-acetylglucosaminidase activity which 254 
would involve the loss of 223.106 atomic mass units corresponding to a reduced GlcNAc (32). 255 
 Interestingly, Gp110 also displays enzymatic activity against B. subtilis and A. viridans PG 256 
(Figure S1.). This indicates that this enzyme can cleave PG containing amidated meso-DAP or L-257 
lysine residues at position 3 of the peptide stems.  Unlike E. coli PG digestion products, which 258 
essentially contains tetrapeptides stems, both B. subtilis and A. viridans digestion products 259 
mostly contain tripeptide stems. 260 
 261 
DISCUSSION 262 
 263 
In this study, we describe a new endolysin from an uncharacterized phage infecting the 264 
Gram-negative pathogen S. Typhimurium. In silico analysis indicates that this endolysin has a 265 
modular structure harbouring a DUF3380 EAD at the C-terminus and a PG_binding_1 CBD at the 266 
N-terminus. This modular structure is a common feature in endolysins with a Gram-positive 267 
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background (7) but remains rare in endolysins with a Gram-negative background, which are 268 
mostly globular (22). Interestingly, the PG_binding_1 is also almost restricted to Gram-positive 269 
related endolysins (8), although with a few exceptions (Salmonella phage PVP-SE1; 270 
Pseudomonas phages phiKZ, EL, 201phi21, and OBP; and phages infecting Burkholderia and 271 
Erwinia) (21, 23, 33). The DUF3380 domain has been only predicted in endolysins from phages 272 
infecting Burkholderia, Pseudomonas and Erwinia (33) and it is classified as a pfam domain of 273 
unknown function. Noteworthy is the fact that there is another domain with unknown function 274 
(DUF3597, pfam12200) associated to an endolysin but it has only been detected in the 275 
endolysin from the Listeria phage A118 (8, 33). According to our results, the biochemical 276 
analysis of DUF3380 using pure PG revealed that this domain has N-acetylmuramidase (EC 277 
3.2.1.17) activity, cleaving the β-(1,4) bonds between N-acetylmuramic acid and N-278 
acetylglucosamine in the sugar backbone of the PG. In addition, Gp110 can cleave PG with 279 
distinct PG compositions such as in B. subtilis  and A. viridans. Up to 690 proteins have a 280 
predicted DUF3380 domain, among which the large majority is present in bacterial proteins and 281 
only 10% are encoded by bacteriophages (InterPro database), which may indicate a horizontal 282 
transfer. According to the Pfam database, this domain is commonly found associated with a PG 283 
binding domain, however, it is also found in one-domain proteins (InterPro). Recently, using 284 
remote homology detection methods, such as FFAS03 (http://ffas.sanfordburnham.org) and 285 
data from publications collected by PubServer (http://pubserver.burnham.org), DUF3380 was 286 
designated as a family of cell-wall lytic enzymes (34) which is in accordance with our results and 287 
we have confirmed it by cleavage sites determination in the PG. Alignments of some sequences 288 
containing this DUF3380 domain show that Gp110 E101 residue is conserved, suggesting this is 289 
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the catalytic residue. Moreover, this catalytic residue is followed by serine which is a common 290 
feature in lysozymes. However, three-dimensional structure predictions of the DUF3380 291 
domain show a low homology with the tertiary structure of other lysozymes which suggests a 292 
completely different fold. On the contrary, the CBD is strongly conserved, showing high 293 
homology with PG binding domains of other hydrolases. 294 
Comparing the Gp110 specific activity with other endolysins analyzed using the same 295 
method under optimal conditions (Table 1.), this endolysin shows the highest enzymatic activity 296 
described to date, 1.7-fold more active than the second most active endolysin, OBPgp279, 297 
which has also a modular structure and a predicted lysozyme-like muramidase activity (21). 298 
Compared to other Salmonella phage endolysins, Gp110 has a 2.5- and 24.8-fold higher activity 299 
than PVP-SE1gp146 and PsP3gp10, respectively, and even a 85.6-fold higher activity than Lys68 300 
(Table 1.). The optimal pH for Gp110 activity is pH 8 (Figure 1.), in contrast to other previously 301 
described endolysins with Gram-negative background, which have an optimal activity at neutral 302 
pH (21, 23, 22, 35). It is noteworthy that three other endolysins from phages infecting S. 303 
Typhimurium have been reported to show an optimal activity at pH 9.5 (phage SPN1S 304 
endolysin) and pH 8.5 (phage SPN9CC endolysin and Lys394) (36-38), whereas endolysins from 305 
phages infecting S. Enteritidis (PVP-SE1gp146, Lys68 and PsP3gp10) have an optimal activity at 306 
pH 7 (21, 22, 35). In terms of temperature resistance, Gp110 remains active after treatment at 307 
temperatures across the tested range (20-90°C), showing no significant activity loss up to 10 308 
min heat treatments at 60°C and only gradually decreasing at higher temperatures (Figure 2.). 309 
Whereas most endolysins irreversibly lose their enzymatic activity upon exposure to 310 
temperatures around 50°C (37, 39-43), some thermoresistant endolysins have also been 311 
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described, including Lys68 from Salmonella phage phi68 (35), gp146 from Salmonella phage 312 
PVP-SE1 (21), the endolysins from bacteriophages Ph2119 and vB_Tsc2631 infecting the 313 
thermophile Thermus scotoductus (44, 45) and the lysin from deep-sea thermophilic 314 
bacteriophage GVE2 (46). Gp110 shows an intermediate profile with an elevated temperature 315 
resistance compared to most mesophilic endolysins, which may correlate to an increased shelf 316 
life of Gp110. 317 
To verify if the biochemical activity of DUF3380 is translated into an antibacterial 318 
activity, Gp110 (2.5 µM) was tested against P. aeruginosa PAO1 and S. Typhimurium LT2 cells in 319 
the presence or absence of 0.5 mM EDTA as OM permeabilizer. As expected, the antibacterial 320 
activity of the protein without EDTA was very low against both strains due to the OM protective 321 
effect. However, in the presence of EDTA the number of P. aeruginosa PAO1 viable cells was 322 
reduced in a 99.9% approximately. The synergistic effect of EDTA in the antibacterial activity of 323 
endolysins with a Gram-negative background was first described with the endolysin EL188 and 324 
P. aeruginosa (47). The mild antibacterial activity of the endolysin/EDTA combination against S. 325 
Typhimurium LT2 cells was also observed for other endolysins (21, 36, 38) and can be explained 326 
by the lower degree of phosphorylation in Salmonella lipopolysaccharide (LPS) molecules 327 
compared to Pseudomonas LPS. As a consequence, S. Typhimurium LT2 has a significantly lower 328 
amount of stabilizing divalent cations, resulting in a lower susceptibility to the EDTA 329 
permeabilization, compared to P. aeruginosa.  330 
Overall, we have characterized an endolysin with the highest enzymatic activity against 331 
Gram-negative peptidoglycan reported to date. This high Gp110 activity can be explained by its 332 
enzymatically active domain, DUF3380, which was biochemically demonstrated to have N-333 
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acetylmuramidase activity and shows a low degree of homology with lysozymes. These features 334 
render Gp110 a novel attractive candidate for engineering to provide the enzyme with outer 335 
membrane permeabilizing and consequently antibacterial properties.  336 
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TABLES 471 
 472 
Table 1. Comparison of Gp110 specific activity with other endolysins against P. aeruginosa 473 
PAO1. All specific activities were calculated following the method described in (22). 474 
Endolysin Activity (units/µM) Structure Reference
Gp110 34240 Modular This work 
OBPgp279 19979 Modular (29)
LysEC8 17103 Globular Unpublished results
PVP-SE1gp146 13614 Modular (29)
EL188 4735 Modular (28)
201ϕ2-1gp229 4469 Modular (29)
KZ144 2058 Modular (28)
PsP3gp10 1380 Globular (33)
P2gp09 829 Globular (33)
BcepC6Bgp22 786 Globular (33)
Lys68 400 Globular (36)
CR8gp3.5 315 Globular (3)
K11gp3.5 134 Globular (33)
KP32gp15 117 Globular (33)
LysAci7 94 Globular Unpublished results
   
 475 
 476 
FIGURES 477 
 478 
Figure 1. pH dependence of Gp110 enzymatic activity. The muralytic activity of Gp110 is shown 479 
against OM permeabilized P. aeruginosa PAO1 cells resuspended in a universal buffer adjusted 480 
to different pH values. Activity is expressed relative to the maximal muralytic activity at the 481 
optimal pH (pH 8). Each bar represents the mean of triplicate experiments, and error bars 482 
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indicate the standard deviation. A one-way ANOVA and Tukey post-hoc test indicated that 483 
there were no statistically significant differences between the activities at the pH range of 6-9 484 
(all p > .05). 485 
Figure 2. Temperature resistance of Gp110. The residual enzymatic activity of Gp110 was 486 
analyzed after 10 min incubation of the endolysin at different temperatures, ranging from 20°C 487 
to 90°C. PG hydrolase activity is expressed relative to the highest measured activity. 488 
Figure 3. Saturation curve of Gp110 at optimal pH (pH 8). The muralytic activity was quantified 489 
against OM permeabilized P. aeruginosa PAO1 cells according to Briers et al. (2007). The X- and 490 
Y-axes display the amount of Gp110 (in nM) added and the corresponding activity (OD655/min) 491 
measured, respectively. Each data point shows the average and error bars of three replicates. 492 
The insert zooms in on the region with a linear relationship between activity and enzyme 493 
concentration (substrate saturating conditions) 494 
Figure 4. Determination of Gp110 cleavage specificity. (A) LC-MS analysis of E. coli BW25113 495 
Dlpp peptidoglycan digested by mutanolysin and recombinant Gp110. Soluble muropeptides 496 
were reduced and analysed by rp-HPLC coupled to MS. Peaks corresponding to m/z values 497 
matching previously identified muropeptides are numbered. (B) Inferred structures, theoretical 498 
monoisotopic masses, theoretical and observed m/z values of peaks identified in (A). (C) LC-499 
MS/MS analysis of the major disaccharide-peptide (peak 4) solubilised by Gp110. The 500 
fragmentation pattern of the [M+H]+ ion at m/z 942.414 was typical of a disaccharide-501 
tetrapeptide (DS-Tetra). The fragmentation event leading to the loss of a nonreduced GlcNAc 502 
residue (203.078) indicates that Gp110 displays N-acetylmuramidase (lysozyme) activity. The 503 
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sequence of peptide fragments is indicated above their respective m/z values (boxed). A, L-Ala 504 
or D-Ala; a, C-terminal D-Ala; m-DAP, meso-diaminopimelic acid; E, g-D-Glu; MR, reduced 505 
MurNAc; G, GlcNAc. TIC, Total Ion Count. 506 
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